IP Verse

Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same - EP3604339

EP3604339

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Application Number
EP19192973A
Filing Date
Jan 13, 2012
Status
Opposition Rejected
Jul 14, 2023
Grant Date
Mar 10, 2021
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3604339B1 was granted to The Regents OF The University OF California on Mar 10, 2021 following the initial filing on Jan 13, 2012 under the application number EP19192973A . The current legal status of the patent is Opposition Rejected.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JG OPPOSITIONSDec 10, 2021ADMISSIBLE

Patent Citations New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePatent NumberPatent Link
DESCRIPTIONWO9007861
DESCRIPTIONWO9117271
DESCRIPTIONWO9201047
OPPOSITIONWO2005100605
OPPOSITIONWO2008076868
OPPOSITIONWO2010124188
OPPOSITIONWO2011054007
OPPOSITIONWO2011079902
OPPOSITIONWO2012075158
SEARCHUS2010062005

Non-Patent Literature (NPL) Citations New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BASKAR et al., Clin Cancer Res., (20080000), vol. 14, pages 396 - 404-
DESCRIPTION- FORRESTER et al., Cell Mol Life Sci., (20020000), vol. 59, pages 83 - 96-
DESCRIPTION- GALFRE, G.MILSTEIN, C., Methods Enzymol., (19810000), vol. 73, pages 3 - 46-
DESCRIPTION- KOREN, E. et al., Biochim. Biophys. Acta, (19860000), vol. 876, pages 91 - 100-
DESCRIPTION- MACKEIGAN et al., Nat Cell Biol., (20050000), vol. 7, pages 591 - 600-
DESCRIPTION- MASIAKOWSKI et al., J Biol Chem., (19920000), vol. 267, pages 26181 - 26190-
DESCRIPTION- OISHI et al., Genes Cells, (19990000), vol. 4, pages 41 - 56-
DESCRIPTION- OISHI et al., J Biol Chem., (19970000), vol. 272, pages 11916 - 11923-
DESCRIPTION- QUEEN et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 10029 - 10033-
DESCRIPTION- ROBINSON et al., Oncogene, (20000000), vol. 19, pages 5548 - 5557-
DESCRIPTION- SCHLESSINGER J., Cell, (20000000), vol. 103, pages 211 - 225-
DESCRIPTION- SHABANI et al., Tumour Biol., (20070000), vol. 28, pages 318 - 326-
DESCRIPTION- WILSON CGOBERDHAN DCSTELLER H. DROR, "a potential neurotrophic receptor gene, encodes a Drosophila homo log of the vertebrate Ror family of Trk-related receptor tyrosine kinases", Proc Natl Acad Sci USA, (19930000), vol. 90, pages 7109 - 7113-
OPPOSITION- LILJAS et al., "Basic of protein structure", Textbook of Structural Biology, World Scientific, (20090000), pages 11 - 15, XP055911295-
OPPOSITION- Senter, P.D., "Potent antibody drug conjugates for cancer therapy", CURRENT OPINION IN CHEMICAL BIOLOGY, CURRENT BIOLOGY LTD, LONDON, GB, GB , (20090601), vol. 13, no. 3, doi:10.1016/j.cbpa.2009.03.023, ISSN 1367-5931, pages 235 - 244, XP026285196
OPPOSITION- Daneshmanesh A H; Hojjat-Farsangi M; Khan A S; Jeddi-Tehrani M; Akhondi M M; Bayat A A; Ghods R; Mahmoudi A-R; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H, "Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells", Leukemia, Nature Publishing Group UK, London, London, (20120106), vol. 26, no. 6, doi:10.1038/leu.2011.362, ISSN 0887-6924, pages 1348 - 1355, XP037784276
OPPOSITION- WARREN T L, WEINER G J, "SYNERGISM BETWEEN CYTOSINE-GUANINE OLIGODEOXYNUCLEOTIDES AND MONOCLONAL ANTIBODY IN THE TREATMENT OF LYMPHOMA", SEMINARS IN ONCOLOGY, W.B. SAUNDERS, US, US , (20020201), vol. 29, no. 01, SUPPL. 02, doi:10.1053/sonc.2002.30147, ISSN 0093-7754, pages 93 - 97, XP008052295
OPPOSITION- Lisa Berglund, Jorge Andrade, Jacob Odeberg, Mathias Uhlén, "The epitope space of the human proteome", Protein Science, Cambridge University Press, (20080401), vol. 17, no. 4, doi:10.1110/ps.073347208, ISSN 09618368, pages 606 - 613, XP055176015
OPPOSITION- Baskar Sivasubramanian; Kwong Ka Yin; Hofer Thomas; Levy Jessica M; Kennedy Michael G; Lee Elinor; Staudt Louis M; Wilson Wyndham H; Wiestner Adrian; Rader Christoph, "Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia", Clinical Cancer Research, Association for Cancer Research, US, US, (20080115), vol. 14, no. 2, doi:10.1158/1078-0432.CCR-07-1823, ISSN 1078-0432, pages 396 - 404, XP009135221
OPPOSITION- Hudecek Michael; Schmitt Thomas M.; Baskar Sivasubramanian; Lupo-Stanghellini Maria Teresa; Nishida Tetsuya; Yamamoto Tori N.; Bleakley Marie; Turtle Cameron J.; Chang Wen-Chung; Greisman Harvey A.; Wood Brent; Maloney David G.; Jensen Michael C.; Rader Christoph; Riddell Stanley R., "The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor", Blood, American Society of Hematology, US, US , (20101125), vol. 116, no. 22, doi:10.1182/blood-2010-05-283309, ISSN 0006-4971, pages 4532 - 4541, XP086694870
OPPOSITION- CUi Bing; Widhopf George F.; Yu Jian; Martinez Daniel; Avery Esther; Zhang Suping; Chen Liguang; Wu Rongrong; Wu Christina C.N.; Prussak Charles; Kipps Thomas J., "Targeting of Chronic Lymphocytic Leukemia B Cells with a Novel Monoclonal Antibody to ROR1", Blood, American Society of Hematology, US, US , (20111118), vol. 118, no. 21, doi:10.1182/blood.V118.21.984.984, ISSN 0006-4971, page 984, XP086622296
OPPOSITION- Yang J, Baskar S, Kwong K Y, Kennedy M G, Wiestner A, Radar Christoph, "Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.", PLoS ONE, Public Library of Science, US, US , (20110601), vol. 6, no. 6, doi:10.1371/JOURNAL.PONE.0021018, ISSN 1932-6203, pages E21018.1 - E21018.15, XP002670875
OPPOSITION- Abdiche, Et Al, "High-throughput epitope binning assays on label-free array-based biosensors can yield exquisite epitope discrimination that facilitates the selection of monoclonal antibodies with functional activity", PLOS- ONE, (20140301), vol. 9, no. 3, page e92451, XP055509756
OPPOSITION- Guilly Rebagay, Su Yan, Cheng Liu, Nai-Kong Cheung, "ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy", Frontiers in Oncology, Frontiers Research Foundation, CH, CH , (20120101), vol. 2, doi:10.3389/fonc.2012.00034, ISSN 2234-943X, XP055282300
SEARCH- AMIR H DANESHMANESH ET AL, "Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, US, vol. 123, no. 5, doi:10.1002/IJC.23587, ISSN 0020-7136, (20080901), pages 1190 - 1195, (20080610), XP002622341 [A] 1-10 * abstract * * figure 6 *
SEARCH- FUKUDA TETSUYA ET AL, "Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal,antigen and receptor for Wnt5a", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 8, doi:10.1073/PNAS.0712148105, ISSN 0027-8424, (20080226), pages 3047 - 3052, (20080219), XP009135222 [A] 1-10 * abstract * * page 3049, column l, paragraph l - column r, paragraph 3 * * figures 3,4 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents